Abdenour Nabid
Centre de Recherche Clinique Étienne LeBel/CHUS Fleurimont · CRC - CHUS
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Abdenour Nabid as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:38 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT00223171 · Duration of Androgen Blockade Combined With Pelvic Irradiation in Prostate CancersUniversité de Sherbrooke · active not recruiting · Prostate Cancer · principal investigator
- Ph3NCT00223145 · Study on the Role of Hormonal Treatment for Two Dosage Levels of Prostate Radiation Therapy Versus Prostate Radiation Therapy AloneAbdenour Nabid · active not recruiting · Prostate Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:38 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 07:38 UTC. The ranking covers the 200 most relevant of 43 PubMed records, and a shared surname and initials can bring in a namesake. All 43 on PubMed
- Regional Nodal Irradiation in Early-Stage Breast Cancer.N Engl J Med · 2015993 citationsRCR 35.4
- Intermittent androgen suppression for rising PSA level after radiotherapy.N Engl J Med · 2012410 citationsRCR 10.7
- Single versus multiple fractions of repeat radiation for painful bone metastases: a randomised, controlled, non-inferiority trial.Lancet Oncol · 2014220 citationsRCR 7.5
- Randomized trial of antioxidant vitamins to prevent acute adverse effects of radiation therapy in head and neck cancer patients.J Clin Oncol · 2005178 citationsRCR 4.8
- Duration of Androgen Deprivation Therapy in High-risk Prostate Cancer: A Randomized Phase III Trial.Eur Urol · 2018171 citationsRCR 6.3
- A randomized trial of antioxidant vitamins to prevent second primary cancers in head and neck cancer patients.J Natl Cancer Inst · 2005160 citationsRCR 4.1
- Phase III study of efaproxiral as an adjunct to whole-brain radiation therapy for brain metastases.J Clin Oncol · 2006144 citationsRCR 3.5
- Antioxidant vitamins supplementation and mortality: a randomized trial in head and neck cancer patients.Int J Cancer · 2006126 citationsRCR 3.2
- 104 citationsRCR 3.7
- 101 citationsRCR 2.7